TMPRSS4 is a novel type II transmembrane serine protease found at the cell surface that is highly expressed in pancreatic, colon and gastric cancer tissues. However, the biological functions of TMPRSS4 in cancer are unknown. Here we show, using reverse transcription-PCR, that TMPRSS4 is highly elevated in lung cancer tissues compared with normal tissues and is also broadly expressed in a variety of human cancer cell lines. Knockdown of TMPRSS4 by small interfering RNA treatment in lung and colon cancer cell lines was associated with reduction of cell invasion and cell-matrix adhesion as well as modulation of cell proliferation. Conversely, the invasiveness, motility and adhesiveness of SW480 colon carcinoma cells were significantly enhanced by TMPRSS4 overexpression. Furthermore, overexpression of TMPRSS4 induced loss of E-cadherin-mediated cell-cell adhesion, concomitant with the induction of SIP1/ZEB2, an Ecadherin transcriptional repressor, and led to epithelialmesenchymal transition events, including morphological changes, actin reorganization and upregulation of mesenchymal markers. TMPRSS4-overexpressing cells also displayed markedly increased metastasis to the liver in nude mice upon intrasplenic injection. Taken together, these studies suggest that TMPRSS4 controls the invasive and metastatic potential of human cancer cells by facilitating an epithelial-mesenchymal transition; TMPRSS4 may be a potential therapeutic target for cancer treatment.
Introduction
Dysregulation of proteases is a hallmark of cancer. Extracellular proteolytic enzymes, including matrix metalloproteinases (MMPs) and serine proteases, play an important role in cancer invasion and metastasis (Duffy, 1996) . It is well established that proteases contribute to the degradation of the basement membrane and extracellular matrix (ECM) and to tissue remodeling. Beyond that, proteases may be involved in all stages of the development and progression of cancer, including growth, survival, migration, invasion, angiogenesis and metastasis, through both direct proteolytic activity and regulation of cellular signaling and functions (Andreasen et al., 1997; Stetler-Stevenson and Yu, 2001; Egeblad and Werb, 2002; Deryugina and Quigley, 2006) .
A number of reports have indicated that MMPs are upregulated in most types of human cancer, including breast, colorectal, lung, prostate, pancreatic and ovarian cancer; moreover, abundant expression of MMPs is associated with tumor progression and poor survival rates (Mignatti and Rifkin, 1993; Nelson et al., 2000; Egeblad and Werb, 2002) . Furthermore, MMPs can promote cell proliferation by mediating growth factor release from sequestered sites in the ECM while antagonizing apoptosis by cleavage of cell deathinducing ligands (Stetler-Stevenson and Yu, 2001; Egeblad and Werb, 2002) . MMP3 can induce epithelial-mesenchymal transition (EMT), accompanied by increased invasive activity and malignant transformation in mammary epithelial cells (Lochter et al., 1997; Radisky et al., 2005) .
Urokinase-type plasminogen activator is a wellknown serine protease and facilitates cancer cell invasion into the surrounding normal tissue by catalysing the conversion of inactive plasminogen to the active proteinase, plasmin, which can degrade most extracellular proteins (Andreasen et al., 1997; Del Rosso et al., 2002) . Further, increased levels of urokinase-type plasminogen activator correlate with invasive properties and poor prognosis in breast, colon and ovarian malignancies (Andreasen et al., 1997; Duffy, 2002) . The role of other serine proteases in cancer has been less well characterized.
Most members of the serine protease family are either secreted or sequestered in cytoplasmic organelles awaiting signal-regulated release. Recently, type II transmembrane serine proteases (TTSPs) have been recognized as a new subfamily of serine proteases that have in common a proteolytic domain, a transmembrane domain, a short cytoplasmic domain and a variable-length stem region containing modular structural domains (Hooper et al., 2001; Netzel-Arnett et al., 2003; Szabo et al., 2003) . The majority of TTSPs have been implicated in tumor development and progression mainly based on their dysregulated expression. Matriptase/MT-SP1, a TTSP with gelatinase activity, is highly expressed in breast, prostate, ovarian and colorectal cancers (Lin et al., 1999; Benaud et al., 2002; NetzelArnett et al., 2003; List et al., 2006) . Matriptase/MT-SP1 is also implicated in tumor growth and metastasis in a mouse model of prostate cancer (Takeuchi et al., 1999; Galkin et al., 2004) and induces skin tumorigenesis in a transgenic mouse model (List et al., 2005) . Another TTSP, TMPRSS1/hepsin, is highly expressed in hepatomas and ovarian and prostate cancers . However, its role in cancer growth and progression remains controversial (Srikantan et al., 2002; Xuan et al., 2006 ). An additional TTSP, TMPRSS4, which was initially referred to as TMPRSS3 (Wallrapp et al., 2000) , was identified through its strong upregulation in pancreatic cancer, and its deduced sequence of 437 amino acids contains a serine protease domain with putative trypsin-like activity and a transmembrane domain (Wallrapp et al., 2000) . It has also been reported that TMPRSS4 is a diagnostic marker of malignant thyroid neoplasm (Kebebew et al., 2005) . Expression of TMPRSS4 is significantly upregulated in human lung and colorectal cancer tissues (YW Park, Unpublished results). However, the biological functions of TMPRSS4 have not yet been elucidated. In this study, we report the first evidence that TMPRSS4 is an important mediator of invasion, metastasis, migration, adhesion and EMT in human epithelial cancer cells and also modulates in vitro cell growth in a cell type-and/or signaling contextdependent manner, suggesting that TMPRSS4 may represent a novel therapeutic target for cancer.
Results
Expression of TMPRSS4 is upregulated in cancer tissues and cancer cell lines We investigated whether TMPRSS4 expression is upregulated in cancer tissues by examining specimens from eight squamous cell lung cancer patients using semiquantitative reverse transcription-polymerase chain reaction (RT-PCR). TMPRSS4 mRNA was highly elevated in all of the lung cancer tissues tested compared with adjacent normal tissues ( Figure 1a) . We observed similar upregulated TMPRSS4 expression in several lung adenocarcinoma tissues (data not shown). We also examined TMPRSS4 mRNA expression in a variety of human cancer cell lines. In most of the cancer cell lines tested, TMPRSS4 was detected at relatively higher levels than in human umbilical vein endothelial cells, although the levels of TMPRSS4 differed (Figure 1b) . TMPRSS4 was highly expressed in HCT15, HCT116, HT29, Colo205, Caco2 and WiDr cells (colon cancer), and in NCI-H322 (non-small-cell lung cancer) and MCF-7 cells (breast cancer) and was intermediately expressed in SW620 cells (colon cancer). Its expression was weakly detected in NCI-H226, NCI-H460 and A549 cells (non-small-cell lung cancer), and in SW480 cells (colon cancer). The glioblastoma cell line U87MG barely expressed TMPRSS4 mRNA. These results suggest a possible role for TMPRSS4 in cancer development or progression in the colon, lung and breast.
TMPRSS4 knockdown suppresses cancer cell invasiveness
To reduce TMPRSS4 expression, we developed an small interfering RNA (siRNA) duplex that caused significant reduction of TMPRSS4 expression without any detectable change in b-actin expression (Figure 1c) . Following siRNA transfection, substantial knockdown of the TMPRSS4 transcript was observed in NCI-H322, Colo205 and HCT15 cells (Figure 1d ). siRNA-mediated depletion of TMPRSS4 resulted in significant suppression of cell invasion of a reconstituted basement membrane (Matrigel) compared with scrambled siRNA (Figure 1d) . Specifically, during a 72-h period, the number of invading cells was reduced by 67% (NCI-H322 cells), 96% (Colo205 cells) and 76% (HCT15 cells). Migration of NCI-H322 cells was also inhibited by TMPRSS4 knockdown (data not shown).
TMPRSS4 overexpression induces invasion and migration of cancer cells
To examine the effect of TMPRSS4 overexpression on the development of malignant characteristics in cancer cells, stable myc-tagged TMPRSS4-expressing cell lines were established using human colon adenocarcinoma SW480 cells that normally display a low level of endogenous TMPRSS4. TMPRSS4 mRNA levels in two isolated TMPRSS4 transfectants (T4 and T17) were increased about 3.5-fold compared with parental SW480 cells or an empty vector transfectant (Figure 2a ). An approximately 57-kDa TMPRSS4 protein tagged with myc at the N-terminus was detected only in the T4 and T17 transfectants, as expected (Figure 2a ). This value is somewhat higher than the calculated molecular mass of 49 kDa, suggesting the presence of glycosylation. Subcellular fractionation and western blot analysis showed signals only in the plasma membrane-enriched fraction of cells transfected with TMPRSS4; intact TMPRSS4 was detected (Figure 2b , arrow) and a signal of smaller size was also detected (Figure 2b, arrowhead) , suggesting the possibility that the TMPRSS4 extracellular domain fragment may be released from cells.
We first examined in vitro cellular invasiveness of the cells overexpressing TMPRSS4. As shown in Figure 2c , TMPRSS4 promotes invasion, metastasis and EMT H Jung et al the number of invading cells increased several-fold over parental and vector-transfected cells when TMPRSS4 was overexpressed. Notably, transfectant T17, which showed higher expression of TMPRSS4 protein than transfectant T4, also exhibited higher invasive potential, indicating that invasive activity correlates with TMPRSS4 expression level. We also found that both TMPRSS4-overexpressing transfectants displayed significantly enhanced motility toward collagen I compared with parental and vector-transfected cells ( Figure 2c ). Next, cells were treated with scrambled siRNA or TMPRSS4-specific siRNA and subjected to an invasion assay. Whereas no apparent effect was observed on parental SW480 cell invasion by TMPRSS4 siRNA, depletion of TMPRSS4 markedly suppressed the invasion of T17 cells (Figure 2d ), confirming that enhancement of To explore whether the enhanced invasiveness of transfected T17 cells was mediated by MMP(s), T17 cells were exposed to general MMP inhibitors during the invasion assay. Up to 25 mM of GM6001 and AG3340 appeared to moderately inhibit the invasiveness of T17 cells (Figure 2e, upper) . In contrast, treatment with 100 mM AEBSF, a serine protease inhibitor, dramatically abolished the invasiveness of T17 cells and vectortransfected cells (Figure 2e , lower) but did not affect cell viability (data not shown). Taken together, these results suggest that TMPRSS4 induces cancer cell invasion in a manner that is partially dependent on MMP(s) but mainly dependent on serine proteolytic activity (see Discussion).
The TMPRSS4 extracellular domain cleaves a peptide substrate of trypsin To analyse the putative serine protease activity of TMPRSS4, the extracellular domain (residues 54-437) of TMPRSS4 was tagged with Fc and myc and then expressed and secreted from 293E cells. Western blotting using anti-myc revealed a B75-kDa band from the conditioned medium, which is somewhat higher than the calculated molecular mass of 71 kDa (Figure 2f, left) . A slight shift in molecular mass was detected after PNGase F treatment (data not shown), suggesting the presence of glycosylation. Conditioned medium containing the recombinant TMPRSS4 extracellular domain fusion protein had enzymatic activity toward the fluorescent peptide substrate for trypsin, t-butyloxycarbonyl (t-Boc)-Gln-Ala-Arg-7-amido-4-methylcoumarin, whereas the 
TMPRSS4 knockdown inhibits cell-matrix adhesion
To investigate the effect of reduced TMPRSS4 expression on cell-matrix interactions that may influence invasion, cell adhesion to collagen I, fibronectin and Matrigel was assessed following siRNA-mediated knockdown of TMPRSS4. As shown in Figure 3a , TMPRSS4-specific siRNA-treated NCI-H322 cells exhibited reduced adhesion to collagen I, fibronectin and Matrigel-coated plastic (by 40, 32, and 65%, respectively) compared with cells treated with scrambled siRNA. These results indicate that TMPRSS4 can modulate cell-matrix interactions, possibly through direct binding to the ECM or via regulation of cell-matrix adhesion receptors such as integrin(s).
TMPRSS4 overexpression stimulates cancer cell adhesion and spreading onto ECM proteins
We then addressed cell adhesion to ECM proteins by the transfectants overexpressing TMPRSS4. Cell adhesion of transfectants T4 and T17 to collagen I, fibronectin and Matrigel increased compared with the parental and vector-transfected cells ( Figure 3b ). To investigate the involvement of an integrin(s) in this event, adhesion was examined in the presence of an GRGDSP (RGD) peptide, a well-known antagonist of several integrins that recognize ligands in the context of the RGD sequence (for example, a5b1-fibronectin) (Aplin et al., 1998) . RGD peptide treatment markedly abolished cell adhesion to fibronectin under conditions where the control GRGESP (RGE) peptide displayed little or no significant effect ( Figure 3c ). Western blot analysis revealed that integrin subunit a5 was clearly upregulated in cell lysates of T17 and T4 cells as compared with parental and vector-transfected cells (Figure 3d ), suggesting that enhanced cell adhesion of T17 and T4 cells may correlate with an increase in integrin expression. During cell spreading within 1 h after initial cell attachment to collagen I-coated dishes, T17 and T4 cells exhibited more rapid and enhanced cell spreading, with membrane ruffles, than the parental or vectortransfected cells (Figure 3e ). In general, T17 cells displayed more spreading than the T4 TMPRSS4 transfectant. These results indicate that TMPRSS4 overexpression can stimulate cell adhesion and spreading onto ECM proteins in mainly an integrin(s)-dependent manner.
TMPRSS4 knockdown modulates in vitro growth of NCI-H322 lung cancer cells
To explore the effect of reduced TMPRSS4 expression on cell growth, cell proliferation in the presence or absence of serum was evaluated using a colorimetric WST assay. Over a 3-day period, 36% fewer TMPRSS4 siRNA-transfected NCI-H322 cells than scrambled siRNA-transfected cells were observed in the presence of serum (Figure 4a , left). A more obvious difference was observed with serum deprivation (Figure 4a , right), with 44% fewer TMPRSS4 siRNA-transfected NCI-H322 cells observed. This indicates that inhibition of TMPRSS4 expression can slow cell proliferation and sensitize cells to serum starvation. To determine which signaling pathway is related to TMPRSS4 function, phosphorylation of the signaling proteins extracellular signal-regulated kinase (ERK)1/2 and p38 mitogenactivated protein kinase (MAPK) of siRNA-treated cells was assessed. TMPRSS4-suppressed cells displayed significantly reduced activation of ERK1/2 and p38 MAPK compared with control cells (Figure 4b ). We also observed that DNA synthesis was reduced by knockdown of TMPRSS4, along with reduction of cyclin D1 and cyclin A and induction of the cdk2 4 cells per insert in the presence of GM6001, AG3340 or 4-(2-Aminoethyl)-benzenesulfonyl fluoride (AEBSF) at the indicated concentrations. DMSO (1%) (D) was used as a vehicle control for GM6001 and AG3340. All determinations were performed at least in triplicate in three independent experiments. Bars, s.d. *Po0.05; **Po0.01; ***Po0.001. Each P-value was calculated with the parental cell or vector transfectant, whichever was higher in (c). (f) Proteolytic activity of the TMPRSS4 extracellular domain. Left, plasmid pCMV-TMPRSS4ECD-Fc-myc expressing an Fc-and myc-tagged fusion of the TMPRSS4 extracellular domain (TMPRSS4-ECD) and empty plasmid pCMVFc-myc (Mock) were introduced into 293E cells. Following a 48-h incubation, the medium was changed to a serum-free medium and conditioned medium was collected for 6 days. The secreted protein was analysed by western blotting using anti-myc. The arrowhead indicates the TMPRSS4 extracellular domain fusion protein. Right, 40-fold concentrated conditioned media (TMPRSS4-ECD and Mock) were incubated with 100 mM fluorescent peptide trypsin substrate, t-butyloxycarbonyl (t-Boc)-Gln-Ala-Arg-7-amido-4-methylcoumarin, in 100 mM Tris, pH 8.0, in the presence or absence of 1 mM AEBSF at 25 1C. Fluorescence intensity was measured with excitation at 380 nm and emission at 460 nm. RT-PCR, PCR with reverse transcription; SDS-PAGE, sodium dodecyl sulfatepolyacrylamide gel electrophoresis; HPFs, high-power fields; DMSO; siRNA, small interfering RNA.
TMPRSS4 promotes invasion, metastasis and EMT H Jung et al inhibitors p21 and p27 (Figures 4c-d) . Taken together, these results indicate that TMPRSS4 modulates cell proliferation by downregulating cell cycle progression.
There was no significant difference in the growth rates of parental, vector-transfected and TMPRSS4-transfected SW480 cells (T4 and T17) grown with or without serum to subconfluency (data not shown).
TMPRSS4 overexpression is associated with morphological changes and actin cytoskeleton rearrangement Comparison of the morphology of the parental SW480 cells, the vector transfectant and two TMPRSS4 transfectants grown at low density revealed enhanced spreading of the T4 and T17 cells (Figure 5a ). The T17 Western blot was performed as described in (b). b-Actin was an internal control. MAPK, mitogen-activated protein kinase; siRNA, small interfering RNA; ERK, extracellular signal-regulated kinase; cdk, cyclin-dependent kinase. vinculin Figure 5 Overexpression of TMPRSS4 induces substantial morphological changes and EMT in SW480 cells concomitantly with the loss of epithelial markers and expression of mesenchymal markers. (a) Upper two rows, phase-contrast images of parental SW480 cells (P), vector transfectant (V) and the two TMPRSS4 transfectants (T4 and T17) cultured on plastic culture dishes in culture medium containing 10% serum. Scale bars, 50 mm. Lower three rows, immunofluorescence analysis of F-actin, vinculin and E-cadherin. Cells were plated on serum-coated glass coverslips for 48 h and stained with rhodamine-labeled phalloidin for F-actin, FITC-conjugated anti-vinculin or with anti-E-cadherin followed by FITC-conjugated secondary antibody. Scale bars, 50 mm (actin and E-cadherin) and 25 mm (vinculin). (b, c) Analysis of EMT markers. Vector-transfectant (V), T17 and T4 cells were seeded in sparse culture and at complete confluency. Following a 2-day incubation, cells were lysed and semiquantitative RT-PCR and western blotting were performed. Cadherin-11 and P-cadherin levels were analysed by semiquantitative RT-PCR. SMA, fibronectin and ZO-1 were analysed by western blotting. b-actin and GAPDH were internal controls. SMA, smooth muscle actin; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; FITC, fluorescein isothiocyanate; EMT, epithelial-mesenchymal transition; RT-PCR, reverse transcription-PCR.
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became more pronounced with progressively higher cell densities.
Immunofluorescence analysis of actin showed that the TMPRSS4 transfectants induced more stress fibers and filopodia-like structures between cells when compared with parental and vector-transfected cells (Figure 5a ). TMPRSS4 transfectants also exhibited an enhanced number of focal adhesion spots when stained with anti-vinculin (Figure 5a ). (Note that plastic culture dishes were used in the morphologic studies, whereas glass coverslips were used in the cell staining studies, which may explain the subtle differences in cell appearance.) TMPRSS4 overexpression induces an EMT associated with SIP1/ZEB2 induction and E-cadherin loss in SW480 cells Because loss and/or reduction of E-cadherin expression correlates positively with tumor cell invasion and metastasis and is a key hallmark of EMT (Thiery, 2002; Thiery and Sleeman, 2006) , regulation of E-cadherin in cells overexpressing TMPRSS4 was assessed. Consistent with reports from other groups (Brabletz et al., 2001; Conacci-Sorrell et al., 2003) , we found that expression of E-cadherin in SW480 cells (data not shown) and the vector transfectant (Figure 5b ) was induced with increasing cell confluency. However, E-cadherin expression was markedly reduced in T17 and T4 cells at both the mRNA and protein levels (Figure 5b ) when compared with the vector transfectant, regardless of whether cells were seeded and grown for 2 days in sparse culture (5 Â 10 3 cells cm
À2
) or at confluency (8 Â 10 4 cells cm À2 ). No extracellular domain fragment of E-cadherin was shed from T17 and T4 cells (data not shown), indicating that cleavage of E-cadherin may not be involved in TMPRSS4 action. Immunofluorescence analysis also showed that T17 and T4 cells displayed significantly reduced E-cadherin levels, whereas parental SW480 and vector-transfected cells maintained E-cadherin expression in organized cell junctions (Figure 5a ). Furthermore, Smad-Interacting Protein 1 (SIP1/ZEB2) (Comijn et al., 2001; Vandewalle et al., 2005) , an E-cadherin transcriptional repressor/ EMT-inducing transcriptional repressor, was concomitantly strongly induced in T17 and T4 cells (Figure 5b ). We examined other EMT markers: TMPRSS4-overexpressing T17 cells displayed upregulation of mesenchymal markers such as cadherin-11, fibronectin and smooth muscle actin and downregulation of ZO-1, Pcadherin ( Figure 5c ) and b-catenin at the plasma membrane (data not shown) compared with control cells. A p120ctn isoform switch from 100 kDa (short) to 120 kDa (long) was also detected (Figure 5b ) along with cadherin switching, which is suggested to be involved in tumor progression (van Hengel and van Roy, 2007) . Meanwhile, no significant changes were observed in Ncadherin and vimentin (data not shown). These results suggest that TMPRSS4 can inactivate E-cadherinmediated cell-cell contact to promote an EMT, thereby enhancing motility and invasiveness.
Overexpression of TMPRSS4 promotes metastasis of SW480 cells
We next determined whether TMPRSS4 influences the behavior of tumors in vivo. Parental SW480 or TMPRSS4-overexpressing T17 cells were injected into the spleen of nude mice. When compared with parental SW480 cells, T17 cells showed marked metastasis to the liver in nude mice (Figures 6a and b) . Metastatic liver nodules were confirmed histologically (Figure 6c) . No lung and portal lymph node metastases were found in either group. In addition, when tumor masses that had been formed from s.c. xenografts were implanted orthotopically (in the cecum) in other nude mice, the number of tumor emboli in peritumoral lymphovasculature was significantly higher in mice implanted with tumor mass from T17 cells compared with control cells (data not shown), suggesting that intravasation of tumor cells is increased by TMPRSS4 expression. Taken together, these results show that TMPRSS4 plays a key role in driving metastasis of human tumor cells in vivo.
Discussion
We report here that TMPRSS4 plays a role in invasion, metastasis, migration and adhesion, as well as in the EMT in cancer cells and that it also modulates cell growth in a cell type-dependent manner. In addition, we also note that TMPRSS4 expression is upregulated in lung cancer tissues compared with normal tissues, and various cancer cell lines themselves express TMPRSS4 at various levels. TMPRSS4 appears to be distinct from the well-known serine protease urokinase-type plasminogen activator and most MMPs in that those proteases are usually derived from stromal cells in cancer tissue rather than from the cancer cells themselves. We found that depleting TMPRSS4 in cell lines established from lung and colon cancers using siRNA affected cell proliferation via regulation of cell cycle progression, invasion and adhesion in vitro, which may be a result of downregulation of ERK1/2 and p38 MAPK activation. p38 MAPK has been reported to be involved in various metastatic processes (Laferriere et al., 2002; Huang et al., 2005) . It is intriguing to consider that TMPRSS4 may modulate the activation of MAPKs to contribute to a malignant phenotype of cancer cells. Our study appears to provide the first evidence that a TTSP family member is positively involved in cancer cell proliferation in vitro; others have reported that inhibition of matriptase/MT-SP1 or TMPRSS1/ hepsin does not affect cell proliferation in vitro, although cell invasion is impaired (Galkin et al., 2004; Suzuki et al., 2004; Forbs et al., 2005; Xuan et al., 2006) . However, in contrast to the reduced cell proliferation observed following knockdown of TMPRSS4 in NCI-H322 cells, TMPRSS4 overexpression does not appear to confer a growth advantage to colon cancer SW480 cells in vitro. Therefore, TMPRSS4 may regulate cell proliferation in a cell type-or signaling context-dependent manner.
TMPRSS4 clearly modulates cancer cell invasion and metastasis; knockdown of TMPRSS4 by siRNA greatly reduced cell invasion of the ECM in lung and colon TMPRSS4 promotes invasion, metastasis and EMT H Jung et al cancer cells. Overexpression of TMPRSS4 led to a several-fold increase in both in vitro invasion and in vivo metastasis of SW480 colon cancer cells. It is intriguing that TMPRSS4 induces cancer cell invasion in only a partially MMP(s)-dependent manner; general MMP inhibitors such as GM6001 and AG3340 appeared to only moderately inhibit invasion of SW480 cells overexpressing TMPRSS4. On the other hand, cell invasion induced by TMPRSS4 is mediated mainly by serine protease activity, as a general serine protease inhibitor could block cell invasion. It is worth exploring by which mechanism the serine protease(s) is involved in enhancement of invasion. We found that the TMPRSS4 extracellular domain displayed proteolytic activity toward the standard peptide substrate for trypsin (Gln-Ala-Arg) that was inhibited by a serine protease inhibitor, possibly suggesting that enhanced invasion may be associated with the serine proteolytic activity of TMPRSS4. Information on whether TMPRSS4 on the cell surface has specific/endogenous proteolytic activity and which, if any, native substrates TMPRSS4 can cleave may provide interesting clues to TMPRSS4 function with regard to its possible proteolytic activity.
Attachment and spreading of cells on the ECM, with concomitant formation of stress fibers and focal adhesions, is required for cell migration. In this respect, it is notable that TMPRSS4 modulated cell adhesion, spreading and migration toward ECM proteins. TMPRSS4 knockdown reduced cancer cell attachment and migration, whereas TMPRSS4 overexpression induced cell-matrix adhesion and migration. Furthermore, TMPRSS4-overexpressing SW480 cells showed morphological changes and actin rearrangements that are characteristic of motile fibroblasts. TMPRSS4 also caused enhanced expression of the integrin subunit a5. Integrin expression is often altered in tumors; for example, a5b1 has been centrally implicated in EMT induction and cell motility (Maschler et al., 2005) . The increased adhesion to ECM proteins was efficiently inhibited by the integrin antagonist, RGD peptide. Altogether, these results suggest that TMPRSS4 can modulate the cell-matrix interaction mainly through regulation of integrins such as a5b1, which probably contributes to enhanced motility and invasiveness.
The Rho family of GTPases, such as RhoA, Rac1 and Cdc42, mediate cytoskeletal dynamics (Nobes and Hall, 1995) and are crucial regulators of both cell motility and cadherin-dependent cell-cell adhesion (Braga, 2002) . It has been suggested that increased expression of mesenchymal cadherins such as N-cadherin and cadherin 11 increases the motility and invasiveness of epithelial cells (Hazan et al., 2000; Feltes et al., 2002) . Here, TMPRRS4-overexpressing SW480 cells displayed membrane ruffling and lamellipodia formation. In addition, TMPRSS4 induced upregulation of cadherin 11 and downregulation of E-cadherin and P-cadherin. Therefore, it is possible that aberrant expression or redistribution of motility-mediating cadherins concurrent with localized regulation of Rho family activity could contribute to cell motility in TMPRSS4-overexpressing colon cancer cells. 
TMPRSS4 promotes invasion, metastasis and EMT H Jung et al
EMT is a process implicated in the conversion of early-stage tumors to invasive malignancies whereby epithelial cell layers lose polarity and cell-cell contact and undergo dramatic cytoskeletal remodeling (Thiery, 2002; Thompson et al., 2005; Thiery and Sleeman, 2006) . Here we showed that TMPRSS4 contributes to tumor cell invasion and metastasis by promoting an EMT. Loss of E-cadherin transcript, a hallmark of EMT, was induced by TMPRSS4. In an attempt to determine the mechanism by which E-cadherin is downregulated, we examined several well-known E-cadherin transcriptional repressors/EMT-inducing transcriptional repressors; no obvious upregulation of SNAIL, SLUG or TWIST mRNA was detected (data not shown), although we could not rule out the possibility that downregulation of E-cadherin is mediated by alteration of the stability and/or subcellular localization of SNAIL. On the other hand, we observed strong SIP1/ZEB2 induction in TMPRSS4-overexpressing transfectants, suggesting that TMPRSS4-induced EMT correlates with SIP1-mediated transcriptional downregulation of E-cadherin and regulation of other EMT markers. Based on our observations that TMPRSS4 caused significant changes in gene expression/transcript maturation of EMT markers, including cadherin switching, p120ctn isoform switching (van Hengel and van Roy, 2007) , and mesenchymal marker upregulation and changes in cellular behaviors such as substantial morphological changes and enhanced motility and invasiveness, we suggest that TMPRSS4 is a novel regulator of the molecular networks that induce EMT.
Materials and methods
Reagents
Fibronectin, collagen I and GM6001 were purchased from Chemicon (Temecula, CA, USA), Matrigel was obtained from BD Biosciences (San Jose, CA) and AEBSF was obtained from Calbiochem (La Jolla, CA, USA). AG3340 and pcDNA3 (oriP)-FcgRI were kind gifts from Dr GH Lee (Korea Research Institute of Bioscience and Biotechnology, Korea) and Dr I Sandlie (Berntzen et al., 2005) , respectively.
Plasmid and cDNA constructs A cDNA encoding wild-type full-length human TMPRSS4 was provided by the National Genome Information Center (Daejon, Korea). A fragment containing the coding sequence of TMPRSS4 was transferred to the expression vector pCMVTag3 (Stratagene, La Jolla, CA, USA) to produce pCMV-myc-TMPRSS4. A leader sequence (GenBank accession number M19901) and Fc and myc tags were inserted into pcDNA3(oriP)-FcgRI digested with HindIII and XhoI to produce pCMVFc-myc, to which a cDNA fragment with the sequence encoding the extracellular domain of TMPRSS4 was ligated to produce pCMV-TMPRSS4ECD-Fc-myc.
Cell lines
All human cell lines were obtained from the American Type Culture Collection, Manassas, VA, USA and maintained as they suggested. Human umbilical vein endothelial cells were maintained using an EGM-2 BulletKit (Cambrex BioScience, Walkersville, MD, USA). Cells were confirmed to be free of mycoplasma.
Reverse transcription-PCR from cell lines Total RNA was isolated from each cell line using a High Pure RNA Isolation kit (Roche, Mannheim, Germany). The RNA (5 mg) was denatured for 10 min at 70 1C and then reverse transcribed with oligo(dT) primers using SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA, USA) for 1 h at 42 1C. The reverse transcriptase was inactivated at 90 1C for 2 min. PCR amplification was performed with TMPRSS4-specific primers (5 0 -CCGATGTGTTCAACTGGAAG-3 0 and 5 0 -CCC ATCCAATGATCCAGAGT-3 0 ), E-cadherin-specific primers (5 0 -GGTTATTCCTCCCATCAGCT-3 0 and 5 0 -CTTGGCTG AGGATGGTGTA-3 0 ), cadherin-11-specific primers (5 0 -ACC AGATGTCTGTGTCAGA-3 0 and 5 0 -GTCATCCTTGTCAT CTGCA-3 0 ), P-cadherin-specific primers (5 0 -ATGACGTGGC ACCAACCAT-3 0 and 5 0 -GTTAGCCGCCTTCAGGTTCTC-3 0 ) and SIP1-specific primers (5 0 -TCTCGCCCGAGTGAAGCC TT-3 0 and 5
and 5 0 -CAAACATGATCTGGGTCATCTTCTC-3 0 ) or glyceraldehyde 3-phosphate dehydrogenase (5 0 -TGATGACATCAAGA AGGTGGTGAAG-3 0 and 5 0 -TCCTTGGAGGCCATGTGG GCCAT-3 0 ) was also amplified as an internal control. PCR was conducted with an annealing temperature of 59 1C for TMPRSS4, 58 1C for SIP1, cadherin-11 and P-cadherin and 55 1C for the others.
Reverse transcription-PCR from fresh tissues Eight squamous cell lung cancer samples and adjacent normal tissue samples were obtained from surgically resected specimens at Korea Cancer Center Hospital (Seoul, Korea). Informed consent was obtained from patients for the use of specimens for research purposes only. Total RNA was isolated using TRIZOL reagent (Invitrogen). RT-PCR was performed for TMPRSS4 and b-actin as described in the previous section.
Transfection and generation of stable cell lines Human colon adenocarcinoma SW480 cells were stably transfected with pCMV-myc-TMPRSS4 or pCMV-Tag3 with Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. G418-resistant clones were selected at 600 mg ml À1 G418 and analysed by western blotting for expression of myc-tagged TMPRSS4 or by RT-PCR for TMPRSS4 mRNA.
Western blot analysis Cells were lysed with RIPA buffer and analysed as described (Kim et al., 2002) using the antibodies anti-myc 4A6 (Upstate, Lake Placid, NY, USA), anti-E-cadherin, anti-p120ctn, anti-p21, anti-p27 (BD Biosciences), anti-actin, anti-cyclin A, anti-cyclin E (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-ZO-1 (Invitrogen), anti-fibronectin (Chemicon), anti-smooth muscle actin (Sigma, St Louis, MO, USA), anti-phospho-ERK1/2, anti-ERK1/2, anti-phosphop38 MAPK, anti-p38 MAPK, anti-cyclin D1 (Cell Signaling, Danvers, MA, USA) and anti-integrins a5 (BD Biosciences), and b1 (Chemicon).
Subcellular fractionation
Subcellular fractions were prepared from transiently transfected SW480 cells with pCMV-myc-TMPRSS4 or pCMVTag3 as reported (Wallrapp et al., 2000) . The plasma membrane-enriched fraction and the cytosolic fraction were analysed by western blotting.
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Small interfering RNA (siRNA) To knockdown TMPRSS4 expression, three synthetic siRNA duplex oligomers were designed and purchased from Invitrogen. A scrambled siRNA duplex was also obtained as a negative control. To identify siRNA(s) that substantially reduce TMPRSS4 expression, human embryonic kidney 293 T cells were co-transfected with pCMV-myc-TMPRSS4 and each siRNA duplex using Lipofectamine 2000. At 48 h posttransfection, cells were lysed to determine the TMPRSS4 level by western blotting. The sequence of the selected TMPRSS4 siRNA was 5 0 -AAGUUGUCGAAACAGGCAGAGAACC-3 0 . NCI-H322 cells were transfected with siRNA using Lipofectamine 2000. Colo205, HCT15, SW480 and T17 cells were transfected by electroporation according to the manufacturer's instructions (Incyto, Seoul, Korea) . At 48 h posttransfection, cells were harvested and subjected to an invasion assay, adhesion assay, or proliferation assay and the TMPRSS4 level was determined by RT-PCR or western blotting.
Invasion and cell migration assays Cells were plated in serum-free medium on 24-well Transwell inserts (Costar, Corning, NY, USA) coated with 100 ml of Matrigel (250 mg ml
À1
). The underside of the insert was precoated with 100 ml of collagen I (10 mg ml À1 ). After incubation for 48 or 72 h at 37 1C/5% CO 2 , the inserts were fixed with 3.7% paraformaldehyde/phosphate-buffered saline and stained with 2% crystal violet. Where indicated, cells were plated onto the inserts with AEBSF, GM6001, AG3340 or 1% DMSO. Cell migration assays were performed in a similar manner but without the Matrigel coating.
Cleavage of a synthetic trypsin substrate 293E cells were transfected with pCMV-TMPRSS4ECD-Fcmyc using Lipofectamine 2000. At 2 days after transfection, the medium was changed to serum-free medium. Conditioned medium was collected for 6 days, and the secreted Fc-and myc-tagged TMPRSS4 extracellular domain fusion protein was analysed by western blotting using anti-myc. To examine the proteolytic activity of the TMPRSS4 extracellular domain, conditioned medium concentrated 40-fold with a Centricon centrifugal filter unit (Millipore, Billerica, MA, USA; 10-kDa cutoff) was incubated with 100 mM t-butyloxycarbonyl (t-Boc)-Gln-Ala-Arg-7-amido-4-methylcoumarin (Sigma) in 100 mM Tris, pH 8.0 at 25 1C. The fluorescence resulting from hydrolysis of the peptide substrate was measured at 380/460 nm using a Victor3 plate reader (PerkinElmer, Wellesley, MA, USA).
Adhesion assay
Cells were seeded into 96-well Maxisorp plates (NUNC, Roskilde, Denmark) coated with collagen I, fibronectin or Matrigel at the concentrations indicated in the figure legends. After a 30-min incubation at 37 1C/5% CO 2 , adherent cells were fixed and stained. Where indicated, cells were preincubated with 300 mg ml À1 peptide RGD or RGE (Peptron, Daejon, Korea) for 15 min before the adhesion assay. In separate experiments, within 1 h after cell attachment, the cells were fixed, stained and photographed to examine cell spreading.
Cell proliferation assay Cells were seeded into 96-well plates at 5000 cells well À1 and incubated at 37 1C/5% CO 2 . Cell proliferation was measured at 1-day intervals for 3 days using the colorimetric WST assay (Takara Bio Inc., Japan). Briefly, cells were incubated with 1/ 10 volume WST reagent, and formazan dye formation was measured at 440 nm using a spectrophotometric microplate reader (Molecular Devices, Sunnyvale, CA, USA). In separate experiments, after cells were attached, the medium was removed and the cells were washed three times with phosphate-buffered saline. Fresh medium lacking serum was then added. Bromodeoxyuridine incorporation was measured colorimetrically to assess the DNA synthesis level according to the manufacturer's instructions (Boehringer-Mannheim, Mannheim, Germany).
Immunocytochemistry
Cells were plated on serum-coated glass coverslips and incubated for 48 h. Cells were fixed for 5 min in 3.7% formaldehyde/phosphate-buffered saline and permeabilized in 0.3% (v v
À1
) Triton X-100 for 3 min. Cells were incubated with rhodamine-phalloidin (Molecular Probes, Inc., Eugene, OR, USA), anti-vinculin fluorescein isothiocyanate conjugate (Sigma) or anti-E-cadherin (Invitrogen) followed by a fluorescein isothiocyanate-conjugated secondary antibody. Cells were counterstained with 4,6-diamidino-2-phenylindole (Sigma).
Morphologic analysis
Cells were grown in culture medium in plastic culture dishes and imaged at both sparse and confluent densities at Â 100 magnification.
Experimental liver metastasis model
Experiments were performed with 6-week-old athymic female BALB/c nu/nu mice (Japan SLC, Japan) in accordance with the guidelines and with the approval of the Institutional Animal Care and Use Committee, Chonnam National University. Mice were anesthetized with ketamine (25 mg kg À1 ) by i.p. injection and enthrone inhalation. A small incision was created in the left upper abdomen and the spleen was exteriorized. Parental SW480 and T17 cells (1 Â 10 6 in 100 ml phosphate-buffered saline) were injected into the splenic pulp through a 30-gauge needle, which was removed 40 min after injection and the laparotomy was then closed in two layers by using 6-0 absorbable sutures. All animals were killed at 7 weeks post-implantation. Liver, lung and portal lymph nodes were excised and fixed in 4% paraformaldehyde for 24 h. Metastatic foci on the hepatic surface were counted macroscopically aided by a surgical telescope and were confirmed microscopically. Paraffin-embedded 4 mm-thick tissue sections were stained with hematoxylin and eosin.
Statistical analysis
Statistical analyses were performed using Student's t-tests. Po0.05 was considered statistically significant.
